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Abstract
Background: Long distance running causes acute muscle damage resulting in inflammation and decreased force 
production. Endurance athletes use NSAIDs during competition to prevent or reduce pain, which carries the risk of 
adverse effects. Tart cherries, rich in antioxidant and anti-inflammatory properties, may have a protective effect to 
reduce muscle damage and pain during strenuous exercise. This study aimed to assess the effects of tart cherry juice as 
compared to a placebo cherry drink on pain among runners in a long distance relay race.
Methods: The design was a randomized, double blind, placebo controlled trial. Fifty-four healthy runners (36 male, 18 
female; 35.8 ± 9.6 yrs) ran an average of 26.3 ± 2.5 km over a 24 hour period. Participants ingested 355 mL bottles of tart 
cherry juice or placebo cherry drink twice daily for 7 days prior to the event and on the day of the race. Participants 
assessed level of pain on a standard 100 mm Visual Analog Scale (VAS) at baseline, before the race, and after the race.
Results: While both groups reported increased pain after the race, the cherry juice group reported a significantly 
smaller increase in pain (12 ± 18 mm) compared to the placebo group (37 ± 20 mm) (p < .001). Participants in the 
cherry juice group were more willing to use the drink in the future (p < 0.001) and reported higher satisfaction with the 
pain reduction they attributed to the drink (p < 0.001).
Conclusions: Ingesting tart cherry juice for 7 days prior to and during a strenuous running event can minimize post-
run muscle pain.
Introduction
Long distance running is known to cause acute muscle
damage resulting in acute inflammation [1] and
decreased force production [2] that can last up to 1 week
post-exercise [3]. One proposed mechanism for this acute
response to distance running is that extensive myofibril
disruption triggers a local inflammatory response, exac-
erbating muscle damage [4-9]. Leukotrienes then
increase vascular permeability, attracting neutrophils to
the injury site, resulting in free radical production [10].
Among endurance athletes, NSAIDs are used during
competition to prevent or reduce pain during a race [11].
There are, however, known adverse effects associated
with the use of traditional oral NSAIDs [12], including
gastrointestinal, renal, and cardiovascular adverse events.
Tart cherries are considered a good source of phenolic
compounds with high levels of antioxidant and anti-
inflammatory activity [13,14]. Considering the natural
anti-inflammatory and antioxidant capacity of tart cher-
ries, it is plausible that cherry consumption before and
during strenuous exercise may have a protective effect to
reduce muscle damage and pain.
Consumption of approximately 45 cherries per day has
been shown to reduce circulating concentrations of
inflammatory markers in healthy men and women
[15,16]. Moreover, a recent study of healthy, exercise-
naïve individuals demonstrated efficacy for cherry juice
in decreasing symptoms and strength loss following
eccentric exercise induced muscle damage. Most notably,
there was a preservation of muscle function attributable
to the cherry juice [15]. The specific anti-inflammatory
mechanism by which cherry juice supplementation may
lessen exercise-induced muscle damage is not well under-
stood [16]. However, it is possible that the anti-inflamma-
tory and/or the antioxidant effects of cherry juice may
mediate this secondary response and avoid the prolifera-
tion of myofibrillar disruption [17]. While there are no
* Correspondence: kuehlk@ohsu.edu
1 Department of Medicine, Oregon Health & Science University, Portland, OR, 
USA, 97239
† Contributed equally
Full list of author information is available at the end of the articleKuehl et al. Journal of the International Society of Sports Nutrition 2010, 7:17
http://www.jissn.com/content/7/1/17
Page 2 of 6
studies directly measuring neutrophil and monocyte acti-
vation after exercise, this mechanism may represent a
potential explanation for the reduction in inflammation
and strength losses associated with tart cherry consump-
tion.
The Oregon Hood to Coast relay race presented a
unique opportunity to examine the effects of tart cherry
juice supplementation on acute muscle damage caused by
repeated bouts of running. Covering 315 km from Mt.
Hood to the Oregon coast, the race involves relay teams
of 12 runners who complete 3 race segments each (indi-
vidual total running distance: 22.5 to 31.4 km). Crossing
two mountain ranges, the hilly course provides ample
opportunity for eccentric muscle damage, with individual
running segments descending up to 609 m or ascending
up to 200 m. The purpose of this study was to assess the
effects of tart cherry juice, compared to a placebo cherry
drink, on muscle pain among Hood to Coast runners.
Methods
Subjects
Fifty-four healthy runners participating in the Hood to
Coast relay (36 male, 18 female; 35.8 ± 9.6 yrs) volun-
teered to participate. The study was approved by the uni-
versity's Institutional Review Board and by the Hood to
Coast race director, and all participants gave written,
informed consent. Inclusion criteria included an ability
and willingness to abstain from anti-inflammatory or
pain-relieving drugs, and willingness to refrain from
seeking any other treatment for symptoms of muscle
damage until the completion of the study. Exclusion crite-
ria included recent use of other pain management meth-
ods (including acupuncture, transcutaneous electrical
nerve stimulation, topical medications/anesthetics, mus-
cle relaxants, injections, or systemic steroids). Women
capable of becoming pregnant completed a pregnancy
test to rule out pregnancy prior to participation.
Beverage Preparation
Cherry Juice
The cherry juice was prepared by mixing freshly prepared
tart cherry juice with commercially available apple juice
in a proprietary ratio (Cherrish Inc., Seattle, WA, USA).
Frozen tart cultivar Montmorency cherries were used to
prepare the cherry juice following standard procedures
that simulate industrial processing. The blended juice
was pasteurized by heating it to 85°C, hot packed into
10.5 oz plastic bottles with a three minute hold time to
achieve commercial sterility, and then forced cooled in a
water bath. One 10.5 oz bottle of the juice provided at
least 600 mg phenolic compounds, expressed as gallic
acid equivalents by the method of Singleton and Rossi
[18], and at least 40 mg anthocyanins, calculated as cyani-
din-3-glucoside equivalents by the pH differential
method described by Giusti and Wrolstad [19]. Each bot-
tle contained the equivalent of 45-50 cherries.
Placebo
The placebo was prepared by mixing unsweetened fruit
punch soft drink mix (Kraft Corporation, Ryebrook, New
York, USA; ingredients listed: citric acid, salt, calcium
phosphate, red 40, artificial flavor, ascorbic acid, blue 1)
with water in the proportion recommended by the manu-
facturer (about 2 g/l). Sugar was added to match the con-
centration of soluble solids in the cherry juice blend to a
final concentration of 13 Brix (total percentage soluble
solids by weight). The flavored beverage was then pas-
teurized and bottled following the procedure used for the
juice.
Experimental Design
The design was a randomized, placebo-controlled, dou-
ble-blind trial among 54 runners participating in the
Hood to Coast relay race (Figure 1). Each participant
completed 3 running segments during the race, with indi-
vidual segment distances ranging from 5.6 to 12.4 km and
an average total running distance of 26.3 ± 2.5 km. Partic-
ipants running on the same relay team were assigned to
the same drink condition (n = 28 cherry; n = 26 placebo)
in order to avoid participants inadvertently switching
drinks during the study. Participants completed 3 data
collection sessions: Day 1 - Baseline (7 days prior to race),
Day 7 - Race Start, and Day 8 - Race End. At Baseline,
participants were given 16-355 mL bottles of the drink
(cherry juice or placebo) with instructions to consume
two bottles daily prior to the race (14 bottles over 7 days),
and two bottles during the race (total consumption: 16
bottles). Baseline data collection also included a health
screening by a physician blinded to the participant's drink
condition. Participants assessed their pain intensity dur-
ing each visit on a standard 100 mm Visual Analog Scale
(VAS), with 0 mm indicating 'no pain', and 100 mm indi-
cating 'most severe pain'. The VAS has excellent reliability
for acute pain [20] as well as well-defined thresholds for
meaningful change in pain intensity [21]. After finishing
the race (Day 8), participants completed the VAS pain
scale and a short questionnaire reporting their level of
satisfaction with the pain relief they attributed to the
drink.
Statistical Analysis
Outcome variables were: participants' assessment of pain
(VAS), level of satisfaction with the drink, and willingness
to use the drink in the future. VAS pain scores were ana-
lyzed using [3 (time) × 2 (drink)] mixed-effects regression
(SPSS version 16 for Windows, Chicago, IL). Participant
satisfaction and participant willingness to use the drink
again were analyzed using independent samples t-tests.
Level of significance was set at α = 0.05.Kuehl et al. Journal of the International Society of Sports Nutrition 2010, 7:17
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Results
Baseline Participant Demographics
Of the 54 participants enrolled, 28 were assigned cherry
juice and 26 were assigned the placebo drink (Table 1). A
total of 3 participants (2 cherry, 1 placebo) withdrew
prior to competing the study (1 was lost to follow-up; 1
reported that the drink caused GI distress; 1 took
NSAIDs during study period). Despite the fact that par-
ticipants were randomized into treatment groups, the
cherry group reported significantly higher pain scores
than the placebo group on Day 1 (F(1,49) = 8.00; p < 0.01).
Pain (VAS) at Race Start and Race End
Mixed-effects regression revealed significant main effects
of drink (F(1,49) = 11.50; p < 0.01), time (F(1,49) = 85.51,
p < 0.001) as well as an interaction between drink and
Figure 1 Consort diagram of enrolled participants.Kuehl et al. Journal of the International Society of Sports Nutrition 2010, 7:17
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time (F(1,49) = 22.64, p < 0.001). At Race Start, there were
no differences in mean VAS score between the cherry and
placebo groups (p = 0.38). After completing the race, par-
ticipants in both groups reported more pain; however, the
increase in pain was significantly smaller in the cherry
juice group compared with the placebo group (p < 0.001)
(Table 2).
Participant Satisfaction
Participants in the cherry juice group reported higher
willingness to use the drink again (p < 0.001), higher
overall satisfaction with the drink (p < 0.001), and higher
satisfaction in the pain reduction they attributed to the
drink (p < 0.001) (Table 3).
Discussion
It is well-documented that running for distances in excess
of typical training distances causes acute muscle injury,
and that eccentric muscle actions, such as downhill run-
ning, exacerbate injury and soreness [22]. The Hood to
Coast relay requires participants to run three separate
race segments over an approximately 24 hour period,
including segments that ascend or descend steep terrain.
It is expected, therefore, that Hood to Coast runners will
experience inflammation and pain during the strenuous
race. In our study, runners in both groups reported more
pain upon completion of the race. However, participants
who drank the tart cherry juice twice daily for one week
prior to and the day of the race reported a significantly
smaller increase in pain after the race (mean post-race
increase of 12 mm in the cherry juice group, compared
with a 37 mm increase in the placebo group). The relative
post-race reduction in pain in the cherry group (25 mm
lower V AS than placebo) suggests that tart cherry juice
provided a protective benefit against the acute muscle
pain caused by distance running.
Pain associated with acute muscle injury is most likely
due to oxidative tissue damage which leads to an inflam-
matory response, causing further production of free radi-
cals and augmenting secondary muscle soreness [23-25].
Because of that pathogenesis, nutritional antioxidants
h a v e  b e e n  p r o p o s e d  a s  a  m e a n s  o f  m i t i g a t i n g  m u s c l e
soreness and strength loss caused by damaging exercise
[15]. Tart cherries contain flavinoids and anthocyanins,
with high antioxidant and anti-inflammatory properties
[13,14]. Consumption of about 45 cherries a day has been
shown to reduce circulating inflammatory markers in
healthy men and women [16]. Moreover, Kelley et al.
reported that serum inflammatory markers including C-
reactive protein (CRP) decreased by 25% after 28 days of
consuming Bing sweet cherries [26]. Additionally, when
studied in healthy young adults, consumption of cherry
juice equivalent to 100-120 cherries daily reduced
strength loss and pain associated with exercise-induced
delayed-onset muscle soreness (DOMS) [15]. In our
study, participants consumed two 355 mL bottles of tart
cherry juice daily, (~90 to 100 cherries) for just seven days
prior to and on the day of the race. The attenuated pain in
the cherry juice group suggests that even short term (~1
week) supplementation with tart cherry juice is effective
at reducing the acute pain caused by repeated bouts of
distance running. Our results are similar to those
reported by Howatson et al. [27], in which runners who
consumed tart cherry juice for 5 days prior to and 48
hours after a marathon showed faster recovery of muscle
strength as well as reduced inflammation.
Due to methodological limitations, our results should
be interpreted with caution. One limitation to the study
Table 1: Participant baseline demographics
Placebo Cherry
N2 5 2 6
Age 32.2 ± 9.8 38.2 ± 8.5
Male/Female 15/10 19/7
Baseline VAS (mm)* 6.1 ± 7.9 16.1 ± 15.9
* Baseline VAS significantly different between groups (p < 0.01)
Table 2: Mean pain scores (VAS) at 3 time points (baseline, race start, race end)
Day 1 (Baseline) Day 7 (Race Start) Day 8 (Race End)
Placebo 6.1 ± 7.9 8.0 ± 9.6 45.3 ± 20.5
Cherry 16.1 ± 15.9* 10.6 ± 11.8 22.6 ± 12.6**
Between groups: * p < 0.05; ** p < 0.001Kuehl et al. Journal of the International Society of Sports Nutrition 2010, 7:17
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was the subjective of assessment of pain by participants.
However, the VAS is commonly used to determine acute
levels of pain and has consistent and well-defined clini-
cally meaningful thresholds [21,28]. A second limitation
is the possibility of cross contamination of the interven-
tion and placebo drinks, as participants may have poten-
tially switched drinks to compare flavor and effects. This
limitation was addressed by assigning participants on the
same relay team to the same beverage condition.
Conclusions
In conclusion, tart cherries have high levels of antioxidant
and anti-inflammatory compounds, and are promoted in
lay publications as beneficial for those with arthritis,
muscle pain, and fibromyalgia. The nutraceutical indus-
try is experiencing exponential growth and defining for
whom these products might be beneficial is an important
task. The present study suggests that the administration
of tart cherry juice for eight days reduced symptoms of
exercise-induced muscle pain among runners participat-
ing in a vigorous endurance event. Further research is
needed to examine serum biomarkers and the potential
explanation for the reduction in pain and inflammation
associated with tart cherry consumption.
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